GGrantIndex
Sort

50,496 grants matching lung cancer

Combinations of Receptor-Targeted Alpha Radionuclide Therapy and Immune Checkpoint Inhibitors for Melanoma Treatment

$639,351
Yubin Miao · University Of Colorado Denver · R01 · FY2023 · CA

Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients

$639,331
Robert H Vonderheide · University Of Pennsylvania · P01 · FY2022 · CA

FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Black/African American Smokers

$639,324
Pebbles Fagan · Univ Of Arkansas For Med Scis · P50 · FY2025 · MD

Nanoparticle Drug Delivery in Post-Pneumonectomy Compensatory Lung Growth

$639,273
Connie C. W. Hsia · Ut Southwestern Medical Center · U01 · FY2016 · HL

ECM geometrical and mechanical properties modulate RTK signaling

$639,231
Jay T. Groves · University Of California Berkeley · U01 · FY2018 · CA

ECM geometrical and mechanical properties modulate RTK signaling

$639,231
Jay T. Groves · University Of California Berkeley · U01 · FY2016 · CA

Device for Promoting Survival of Congested Tissue Flaps

$639,098
John A. Russell · Spectrocon, Llc · R44 · FY2010 · HL

Population Health Management Approaches to Increase Lung Cancer Screening in Community Health Centers

$639,095
David W Wetter · University Of Utah · UG3 · FY2024 · CA

Population Health Management Approaches to Increase Lung Cancer Screening in Community Health Centers

$639,095
David W Wetter · Utah State Higher Education System--University Of Utah · UG3 · FY2025 · CA

Clinical Trial of Watercress in Detoxification of Environmental Toxicants and Carcinogens

$639,083
Stephen S Hecht · University Of Minnesota · R01 · FY2020 · CA

A model for predicting response to PD-1 inhibitors in NSCLC

$639,083
Edward B Garon · University Of California Los Angeles · R01 · FY2017 · CA

Clinical Trial of Watercress in Detoxification of Environmental Toxicants and Carcinogens

$638,969
Stephen S Hecht · University Of Minnesota · R01 · FY2021 · CA

A novel preclinical model of spontaneous metastasis

$638,924
Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

IGF::OT::IGF TARGETING THE IL SIGNAL PATHWAY

$638,885
Craig Menges · Research Inst Of Fox Chase Can Ctr · N01 · FY2016 · CA

Chemoprevention of lung cancer with mitochondria-targeted honokiol

$638,820
Ming You · Medical College Of Wisconsin · R01 · FY2020 · CA

Tools to Analyze Morphology and Spatially Mapped Molecular Data

$638,778
Joel H Saltz · State University New York Stony Brook · U24 · FY2018 · CA

Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer

$638,683
Johannes F Fahrmann · University Of Tx Md Anderson Can Ctr · U01 · FY2024 · CA

Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults

$638,669
Darla Elizabeth Kendzor · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · CA

Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer

$638,665
Xiao-Ou Shu · Vanderbilt University Medical Center · R01 · FY2020 · CA

The tumor ecosystem in cancer progression and immunotherapeutic response

$638,655
Alexander Y. Rudensky · Sloan-Kettering Inst Can Research · U54 · FY2020 · CA

ASPH Targeted Therapy for Chondrosarcoma

$638,644
Richard M Terek · Rhode Island Hospital · R01 · FY2023 · CA

Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure

$638,624
Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2020 · ES

Translating buccal nanocytology for lung cancer screening into clinical practice

$638,469
Vadim Backman · Northwestern University · R01 · FY2018 · CA

Antibody Engineering Program

$638,442
Mitchell Ho · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA

National Lung Screening Trial (NLST)

$638,440
Paul Kvale · Henry Ford Health System · N01 · FY2009 · CA